• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

Big pharma in USD230m on opioids with New York

Big pharma in USD230m SETTLEMENT on opioids with New York​

 
KEY POINTS
  • New York Attorney General’s office said the agreement bans J&J from promoting opioids through any means and prohibits lobbying about such products at the federal, state or local levels.
  • However, Johnson & Johnson said it had already exited the business.
  • As part of the settlement, the company will resolve opioids-related claims and allocate payments over nine years.
  • The settlement follows years of lawsuits by states, cities and counties against major pharmaceutical companies over the opioid crisis, which has killed nearly 500,000 people in the U.S. since 1999.
 
Johnson & Johnson has agreed to a $230 million settlement with New York state that bars the company from promoting opioids and confirmed it has ended distribution of such products within the United States.

New York Attorney General Letitia James’ office in a statement Saturday said the agreement bans J&J from promoting opioids through any means and prohibits lobbying about such products at the federal, state or local levels.
 
Johnson & Johnson has not marketed opioids in the U.S. since 2015 and fully discontinued the business in 2020.

As part of the settlement, the company will resolve opioids-related claims and allocate payments over nine years. It could also pay $30 million more in the first year if the state executive chamber signs into law new legislation creating an opioid settlement fund, according to the press release from James’ office.

The settlement follows years of lawsuits by states, cities and counties against major pharmaceutical companies over the opioid crisis, which has killed nearly 500,000 people in the U.S. in the last couple decades.

Governments have argued that companies over-prescribed the drugs, causing people to become addicted and abuse other illegal forms of opioids, while companies have said they’ve distributed the necessary amount of the product to help people with medical issues.

“The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” James said in a statement
 
“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country,” she said. “Opioids will no longer be manufactured or sold in the United States by J&J.”

The New York opioid lawsuit trial against the rest of the defendants will begin this week, according to the release. Other defendants in the New York suit include Purdue Pharma; Mallinckrodt LLC; Endo Health Solutions; Teva Pharmaceuticals USA; and Allergan Finance LLC.

In a statement Saturday, Johnson & Johnson said the settlement “is not an admission of liability or wrongdoing by the company” and is “consistent with the terms of the previously announced $5 billion all-in settlement agreement in principle for the resolution of opioid lawsuits and claims by states, cities, counties and tribal governments.”

The company also said it would continue to defend against any lawsuits the final agreement does not resolve.

James said the state will focus on funding for opioid prevention, treatment and education efforts in order to “prevent any future devastation.”
 
NEW YORK (AP) — Johnson & Johnson has agreed to pay $230 million to New York state to settle claims that the pharmaceutical giant helped fuel the opioid crisis, Attorney General Letitia James said on Saturday.

The drugmaker also agreed to permanently end the manufacturing and distribution of opioids across New York and the rest of the nation, James said in a statement announcing the settlement.

The company "helped fuel this fire, but today they're committing to leaving the opioid business — not only in New York, but across the entire country," she said.
 
The deal involving a lawsuit brought by James in 2019 removes Johnson & Johnson from a trial that is slated to begin next week on Long Island — part of a slew of litigation over an epidemic linked to nearly 500,000 deaths over the last two decades.

In its own statement on Saturday, Johnson & Johnson downplayed the attorney general's announcement. It said the settlement involved two prescription painkillers — developed by a subsidiary and accounting for less than 1% of the market — that are already no longer sold in the U.S.
 
ginfreely said:
The deal involving a lawsuit brought by James in 2019 removes Johnson & Johnson from a trial that is slated to begin next week on Long Island — part of a slew of litigation over an epidemic linked to nearly 500,000 deaths over the last two decades.

In its own statement on Saturday, Johnson & Johnson downplayed the attorney general's announcement. It said the settlement involved two prescription painkillers — developed by a subsidiary and accounting for less than 1% of the market — that are already no longer sold in the U.S.
Click to expand...
Ah we see a lot of this here too. Downplay evil. No one is on trial here but when it comes to criminal behavior it is all the same indeed either no repentance or downplay evil with no admission.
 
The settlement was "not an admission of liability or wrongdoing by the company," Johnson & Johnson said. It added that its actions "relating to the marketing and promotion of important prescription pain medications were appropriate and responsible."

The settlement was the latest development in the complicated universe of opioid-related lawsuits across the U.S. that has drawn comparisons to the multistate litigation against tobacco companies in the 1990s. It reflects a path being taken by some big drug companies that see settling as in their best interests, in part because that route would likely not cost as much as losing in court repeatedly.

Johnson & Johnson — along with distributors AmerisourceBergen, Cardinal Health and McKesson — made public last year that they were offering a total of $26 billion over 18 years to settle all the cases they face, with the money going to abate the crisis.
 
I think j&j talcum problem is much bigger.

BBC Homepage
Search
BBC News

Johnson & Johnson to pay $4.7bn damages in talc cancer case​

Published13 July 2018
commentsComments
Share

In the six-week trial, the women and their families said they developed ovarian cancer after using baby powder and other talc products for decades.
Of the 22 women represented in this case, six have died from ovarian cancer.

Their lawyers alleged the company knew its talc was contaminated with asbestos since the 1970s but failed to warn consumers about the risks.

'Unfair process'​

Talc is a mineral and can sometimes be found in the ground in close proximity to asbestos.
J&J denied that its products ever contained asbestos and insisted that they do not cause cancer.
The pharmaceutical giant added that several studies have shown its talc to be safe and said the verdict was a product of a "fundamentally unfair process".
The US Food and Drug Administration (FDA) commissioned a study of a variety of talc samples, including J&J, from 2009 to 2010. It found no asbestos in any of them.
The prosecution lawyer told the Missouri court that the FDA and Johnson & Johnson had used flawed testing methods.
 
Is Johnson and Johnson the largest pharmaceutical company?

Founded in 1886 in New Brunswick, New Jersey, Johnson & Johnson is one of the largest pharmaceutical, medical device, and consumer packaged goods manufacturers in the world. In 2020, the companygenerated some 82.6 billion U.S. dollars of total revenue.23 Feb 2021
 
You must log in or register to reply here.

Similar threads

k1976
Robot for Your Happy Ending, Boss?
Replies
7
Views
450
k1976
k1976
duluxe
6 suspected terrorists with ISIS ties arrested in sting operation in New York, LA and Philadelphia
Replies
1
Views
447
Pinkieslut
P
duluxe
15 New York synagogues hit with false bomb threats on Friday
Replies
0
Views
634
duluxe
duluxe
ginfreely
Big 3 U.S. drug distributors, and big pharma reach landmark $26 billion opioid settlement
Replies
4
Views
880
ginfreely
ginfreely
Franjipani
US health officials report 1st case of new form of mpox in a traveler
Replies
0
Views
313
Franjipani
Franjipani
Back
Top